With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:
Image source: Getty Images
Megaport Ltd (ASX: MP1)
According to a note out of Citi, its analysts have retained their buy rating and $14.65 price target on this network solutions company's shares. The broker highlights that demand for GPU rentals has been surging, which bodes well for its Latitude business. This is especially the case given how it has been increasing prices, which should be a boost to annual recurring revenue. In fact, Citi believes that there is upside risk to forecasts for 2026 and 2027. Looking ahead, the broker believes there is a strong chance that management will increase its FY 2026 guidance at an event. The Megaport share price is trading at $6.89 on Monday afternoon.
Northern Star Resources Ltd (ASX: NST)
Another note out of Citi reveals that its analysts have retained their buy rating on this gold miner's shares with an improved price target of $29.70. The broker has been busy updating its gold coverage to reflect stronger prices. This has led to a significant increase in earnings estimates for the gold mining industry. Overall, the broker is positive and sees value in Northern Star shares at current levels. So much so, the gold miner is one of its preferred picks in the industry at present. The Northern Star share price is fetching $23.68 at the time of writing.
ResMed Inc. (ASX: RMD)
Analysts at Ord Minnett have retained their buy rating on this sleep disorder treatment company's shares with a trimmed price target of $41.40. According to the note, the broker is expecting ResMed to deliver double-digit earnings and revenue growth in FY 2026. It then expects this trend to continue through to at least FY 2028. Ord Minnett believes this will leave ResMed with a significant cash balance, which it suspects could lead to further capital management activities. Overall, it feels this makes the company a top option for investors at current levels. The ResMed share price is trading at $32.22 this afternoon.
